鼠疫耶尔森菌菌株的体外抗菌药敏情况
In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
作者信息
Smith M D, Vinh D X, Nguyen T T, Wain J, Thung D, White N J
机构信息
Wellcome Trust Clinical Research Unit, Cho Quan Hospital, Ho Chi Minh City, Vietnam.
出版信息
Antimicrob Agents Chemother. 1995 Sep;39(9):2153-4. doi: 10.1128/AAC.39.9.2153.
Abstract
The in vitro activities of 14 antimicrobial agents were determined for 78 strains of Yersinia pestis. The most active antibiotics were ceftriaxone and ciprofloxacin, followed by ofloxacin and ampicillin. The agents traditionally used for the treatment of plague (streptomycin, tetracycline, and chloramphenicol) were considerably less active. Azithromycin showed poor activity against all strains.
摘要
测定了14种抗菌药物对78株鼠疫耶尔森菌的体外活性。活性最强的抗生素是头孢曲松和环丙沙星，其次是氧氟沙星和氨苄西林。传统上用于治疗鼠疫的药物（链霉素、四环素和氯霉素）活性要低得多。阿奇霉素对所有菌株的活性都很差。
相似文献
1
In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
Antimicrob Agents Chemother. 1995 Sep;39(9):2153-4. doi: 10.1128/AAC.39.9.2153.
2
In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
Antimicrob Agents Chemother. 1996 Nov;40(11):2646-7. doi: 10.1128/AAC.40.11.2646.
3
Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.
J Antimicrob Chemother. 2003 Dec;52(6):1029-31. doi: 10.1093/jac/dkg484. Epub 2003 Nov 12.
4
In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
Antimicrob Agents Chemother. 2011 Aug;55(8):3752-7. doi: 10.1128/AAC.01481-10. Epub 2011 May 31.
5
Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents.
Antimicrob Agents Chemother. 2000 Jul;44(7):1995-6. doi: 10.1128/AAC.44.7.1995-1996.2000.
6
Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
Antimicrob Agents Chemother. 2011 Jun;55(6):2623-8. doi: 10.1128/AAC.01374-10. Epub 2011 Apr 12.
7
[Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989].
Arch Inst Pasteur Madagascar. 1989;56(1):37-53.
8
Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania.
J Trop Med Hyg. 1992 Oct;95(5):335-8.
9
[Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
Antibiot Khimioter. 2001;46(8):6-8.
10
In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.
Antimicrob Agents Chemother. 2015 Apr;59(4):1919-21. doi: 10.1128/AAC.04548-14. Epub 2015 Jan 12.
引用本文的文献
1
Antibiotic Therapy of Plague: A Review.
Biomolecules. 2021 May 12;11(5):724. doi: 10.3390/biom11050724.
2
A novel mechanism of streptomycin resistance in Yersinia pestis: Mutation in the rpsL gene.
PLoS Negl Trop Dis. 2021 Apr 22;15(4):e0009324. doi: 10.1371/journal.pntd.0009324. eCollection 2021 Apr.
3
Impact of Gentamicin Concentration and Exposure Time on Intracellular .
Front Cell Infect Microbiol. 2017 Dec 11;7:505. doi: 10.3389/fcimb.2017.00505. eCollection 2017.
4
In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.
Antimicrob Agents Chemother. 2015 Apr;59(4):1919-21. doi: 10.1128/AAC.04548-14. Epub 2015 Jan 12.
5
Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
PLoS One. 2012;7(12):e52503. doi: 10.1371/journal.pone.0052503. Epub 2012 Dec 20.
6
In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
Antimicrob Agents Chemother. 2011 Aug;55(8):3752-7. doi: 10.1128/AAC.01481-10. Epub 2011 May 31.
7
Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.
J Clin Microbiol. 2011 May;49(5):1956-60. doi: 10.1128/JCM.00142-11. Epub 2011 Mar 16.
8
Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
Antimicrob Agents Chemother. 2011 Feb;55(2):822-30. doi: 10.1128/AAC.00818-10. Epub 2010 Nov 29.
9
Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
Antimicrob Agents Chemother. 2007 Aug;51(8):2661-7. doi: 10.1128/AAC.00073-07. Epub 2007 May 21.
10
Resistance of Yersinia pestis to antimicrobial agents.
Antimicrob Agents Chemother. 2006 Oct;50(10):3233-6. doi: 10.1128/AAC.00306-06.
本文引用的文献
1
Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
Antimicrob Agents Chemother. 1994 Mar;38(3):481-6. doi: 10.1128/AAC.38.3.481.
2
Plague in Vietnam 1965-1966.
Am J Epidemiol. 1967 Nov;86(3):603-16. doi: 10.1093/oxfordjournals.aje.a120770.
3
Plague in Vietnam. Clinical observations and treatment with kanamycin.
Arch Intern Med. 1974 Feb;133(2):280-3. doi: 10.1001/archinte.133.2.280.
4
Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.
Antimicrob Agents Chemother. 1987 Apr;31(4):523-6. doi: 10.1128/AAC.31.4.523.
5
[Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989].
Arch Inst Pasteur Madagascar. 1989;56(1):37-53.
6
Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection.
Antimicrob Agents Chemother. 1991 Sep;35(9):1785-90. doi: 10.1128/AAC.35.9.1785.
Zotero 插件